Reviva Pharmaceuticals HoldiRVPH
13F holders, Q2 2026 (June 30)5holders −30
2new positions
33sold out
$0.48avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Reviva Pharmaceuticals Holdi (RVPH) in their 13F filings, down 30 from Q1 2026. 2 opened new positions and 33 sold out. The largest holders were EMC Capital Management ($3K), TD Waterhouse Canada Inc. ($412) and Purpose Unlimited Inc. ($259).
- Company
- Reviva Pharmaceuticals Holdi
- CUSIP
- 76152G209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2 |
| Exits | 33 | $2.1M |
All 13F filers, Q1 2026 → Q2 2026: 2 shares bought and 2,919,074 shares sold, net −2,919,072 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| EMC Capital Management | 0.00% | — | 6,696 | $3K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 625 | $412 |
| Purpose Unlimited Inc. | 0.00% | No change | 405 | $259 |
| Mosley Wealth Management | 0.00% | New | 1 | $1 |
| Miller Global Investments, LLC | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is RVPH's weight in each manager's 13F, not the share of Reviva Pharmaceuticals Holdi the manager owns.